Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125229701 | 12522970 | 1 | I | 20160622 | 20160701 | 20160701 | EXP | PL-ELI_LILLY_AND_COMPANY-PL201606010042 | ELI LILLY AND CO | 62.00 | YR | F | Y | 80.00000 | KG | 20160701 | CN | PL | PL |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125229701 | 12522970 | 1 | SS | HUMULIN 70/30 | INSULIN HUMAN | 1 | Subcutaneous | 26 U, EACH MORNING | U | 0 | 26 | IU | QD | ||||||
125229701 | 12522970 | 2 | SS | HUMULIN 70/30 | INSULIN HUMAN | 1 | Subcutaneous | 14 U, EACH EVENING | U | 0 | 14 | IU | QD | ||||||
125229701 | 12522970 | 3 | PS | HUMULIN N | INSULIN HUMAN | 1 | Subcutaneous | 20 U, QD | U | 18780 | 20 | IU | QD | ||||||
125229701 | 12522970 | 4 | SS | HUMULIN N | INSULIN HUMAN | 1 | Subcutaneous | 8 U, EACH MORNING | U | 18780 | 8 | IU | QD | ||||||
125229701 | 12522970 | 5 | SS | HUMULIN N | INSULIN HUMAN | 1 | Subcutaneous | 10 U, EACH EVENING | U | 18780 | 10 | IU | QD | ||||||
125229701 | 12522970 | 6 | SS | HUMALOG | INSULIN LISPRO | 1 | Unknown | 13 U, EACH MORNING | U | U | 0 | 13 | IU | QD | |||||
125229701 | 12522970 | 7 | SS | HUMALOG | INSULIN LISPRO | 1 | Unknown | 5 U, QD | U | U | 0 | 5 | IU | QD | |||||
125229701 | 12522970 | 8 | SS | HUMALOG | INSULIN LISPRO | 1 | Unknown | 8 U, EACH EVENING | U | U | 0 | 8 | IU | QD | |||||
125229701 | 12522970 | 9 | SS | HUMALOG | INSULIN LISPRO | 1 | Unknown | UNK UNK, PRN | U | U | 0 | ||||||||
125229701 | 12522970 | 10 | SS | Abasaglar | INSULIN GLARGINE | 1 | Subcutaneous | 16 U, QD | U | U | 0 | 16 | IU | QD | |||||
125229701 | 12522970 | 11 | SS | HUMULIN NOS | INSULIN HUMAN | 1 | 42 U, EACH MORNING | U | 0 | 42 | IU | QD | |||||||
125229701 | 12522970 | 12 | SS | HUMULIN NOS | INSULIN HUMAN | 1 | Subcutaneous | 10 U, QD | U | 0 | 10 | IU | QD | ||||||
125229701 | 12522970 | 13 | SS | HUMULIN NOS | INSULIN HUMAN | 1 | Subcutaneous | 28 U, EACH EVENING | U | 0 | 28 | IU | QD | ||||||
125229701 | 12522970 | 14 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 3000 MG, QD | U | 0 | 3000 | MG | QD | |||||||
125229701 | 12522970 | 15 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | 6 MG, UNKNOWN | U | 0 | 6 | MG | ||||||||
125229701 | 12522970 | 16 | C | ACARBOSE. | ACARBOSE | 1 | 300 MG, UNK | U | 0 | 300 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125229701 | 12522970 | 1 | Product used for unknown indication |
125229701 | 12522970 | 3 | Product used for unknown indication |
125229701 | 12522970 | 6 | Product used for unknown indication |
125229701 | 12522970 | 10 | Product used for unknown indication |
125229701 | 12522970 | 11 | Product used for unknown indication |
125229701 | 12522970 | 16 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125229701 | 12522970 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125229701 | 12522970 | Blood creatine decreased | |
125229701 | 12522970 | Blood glucose decreased | |
125229701 | 12522970 | Blood glucose increased | |
125229701 | 12522970 | Gastroenteritis | |
125229701 | 12522970 | Glycosylated haemoglobin increased | |
125229701 | 12522970 | Increased appetite | |
125229701 | 12522970 | Neuroglycopenia | |
125229701 | 12522970 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |